Opus Genetics (IRD) Net Cash Flow (2010 - 2026)
Opus Genetics (IRD) reported Net Cash Flow of $14.9 million for Q1 2026, up 29.61% year-over-year from $11.5 million in Q1 2025, and up 4.15% on a QoQ basis from $14.3 million in Q4 2025.
Opus Genetics (IRD) has 17 years of Net Cash Flow data on file, last reported at $14.9 million in Q1 2026.
- Quarterly Net Cash Flow rose 29.61% year-over-year to $14.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $18.2 million (up 438.37% YoY) and the FY2025 annual result came in at $14.8 million, up 173.19% from the prior year.
- Net Cash Flow grew to $14.9 million in Q1 2026 per IRD's latest filing, from $14.3 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $28.8 million in Q4 2022 and bottomed at -$9.4 million in Q2 2025.
- The 5-year median for Net Cash Flow is -$2.2 million (2022), against an average of $2.1 million.
- The widest annual swing landed in 2022, when Net Cash Flow jumped 1160.03%; it then sank 681.6% in 2024.
- Tracing IRD's Net Cash Flow over 5 years: stood at $28.8 million in 2022, then plunged by 71.68% to $8.2 million in 2023, then tumbled by 177.43% to -$6.3 million in 2024, then surged by 326.21% to $14.3 million in 2025, then climbed by 4.15% to $14.9 million in 2026.
- Per Business Quant, the three latest IRD Net Cash Flow figures stand at $14.9 million (Q1 2026), $14.3 million (Q4 2025), and -$1.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 2.44 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 625.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.44 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 457.40 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -152.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 60.68 Mn |
| 10 | Opus Genetics | 357.99 Mn | 298.03 Mn | - | 14.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.87 Mn |
| Mar 31, 2026 | 14.87 Mn |
| Dec 31, 2025 | 14.28 Mn |
| Dec 31, 2025 | 14.28 Mn |
| Sep 30, 2025 | -1.61 Mn |
| Sep 30, 2025 | -1.61 Mn |
| Jun 30, 2025 | -9.36 Mn |
| Jun 30, 2025 | -9.36 Mn |
| Mar 31, 2025 | 11.47 Mn |
| Mar 31, 2025 | 11.47 Mn |
| Dec 31, 2024 | -6.31 Mn |
| Dec 31, 2024 | -6.31 Mn |
| Sep 30, 2024 | -4.78 Mn |
| Sep 30, 2024 | -4.78 Mn |
| Jun 30, 2024 | -5.75 Mn |
| Jun 30, 2024 | -5.75 Mn |
| Mar 31, 2024 | -3.34 Mn |
| Mar 31, 2024 | -3.34 Mn |
| Dec 31, 2023 | 8.15 Mn |
| Dec 31, 2023 | 8.15 Mn |
| Sep 30, 2023 | 2.37 Mn |
| Sep 30, 2023 | 2.37 Mn |
| Jun 30, 2023 | 989,000.00 |
| Jun 30, 2023 | 989,000.00 |
| Mar 31, 2023 | -3.65 Mn |
| Mar 31, 2023 | -3.65 Mn |
| Dec 31, 2022 | 28.78 Mn |
| Dec 31, 2022 | 28.78 Mn |
| Sep 30, 2022 | -3.17 Mn |
| Sep 30, 2022 | -3.17 Mn |
| Jun 30, 2022 | -2.22 Mn |
| Jun 30, 2022 | -2.22 Mn |
| Mar 31, 2022 | -5.29 Mn |
| Mar 31, 2022 | -5.29 Mn |
| Dec 31, 2021 | 2.28 Mn |
| Dec 31, 2021 | 2.28 Mn |
| Sep 30, 2021 | -1.98 Mn |
| Sep 30, 2021 | -1.98 Mn |
| Jun 30, 2021 | 13.64 Mn |
| Jun 30, 2021 | 13.64 Mn |
| Mar 31, 2021 | -5.80 Mn |
| Mar 31, 2021 | -5.80 Mn |
| Dec 31, 2020 | 15.68 Mn |
| Dec 31, 2020 | 15.68 Mn |
| Sep 30, 2020 | -132,000.00 |
| Sep 30, 2020 | -132,000.00 |
| Jun 30, 2020 | -399,000.00 |
| Jun 30, 2020 | -399,000.00 |
| Mar 31, 2020 | -284,000.00 |
| Mar 31, 2020 | -284,000.00 |
| Dec 31, 2019 | 1.90 Mn |
| Dec 31, 2019 | 1.90 Mn |
| Sep 30, 2019 | 622,051.00 |
| Sep 30, 2019 | 622,051.00 |
| Jun 30, 2019 | 1.19 Mn |
| Jun 30, 2019 | 1.19 Mn |
| Mar 31, 2019 | -2.62 Mn |
| Mar 31, 2019 | -2.62 Mn |
| Dec 31, 2018 | -2.62 Mn |
| Dec 31, 2018 | -2.62 Mn |
| Sep 30, 2018 | -502,553.00 |
| Sep 30, 2018 | -502,553.00 |
| Jun 30, 2018 | -1.20 Mn |
| Jun 30, 2018 | -1.20 Mn |
| Mar 31, 2018 | -2.60 Mn |
| Mar 31, 2018 | -2.60 Mn |
| Dec 31, 2017 | 672,965.00 |
| Dec 31, 2017 | 672,965.00 |
| Sep 30, 2017 | -564,330.00 |
| Sep 30, 2017 | -564,330.00 |
| Jun 30, 2017 | -1.70 Mn |
| Jun 30, 2017 | -1.70 Mn |
| Mar 31, 2017 | -1.09 Mn |
| Mar 31, 2017 | -1.09 Mn |
| Dec 31, 2016 | 3.19 Mn |
| Dec 31, 2016 | 3.19 Mn |
| Sep 30, 2016 | 514,245.00 |
| Sep 30, 2016 | 514,245.00 |
| Jun 30, 2016 | -2.59 Mn |
| Jun 30, 2016 | -2.59 Mn |
| Mar 31, 2016 | 264,214.00 |
| Mar 31, 2016 | 264,214.00 |
| Dec 31, 2015 | -2.25 Mn |
| Dec 31, 2015 | -2.25 Mn |
| Sep 30, 2015 | 2.48 Mn |
| Sep 30, 2015 | 2.48 Mn |
| Jun 30, 2015 | -758,564.00 |
| Jun 30, 2015 | -758,564.00 |
| Mar 31, 2015 | 902,965.00 |
| Mar 31, 2015 | 902,965.00 |
| Dec 31, 2014 | -5.15 Mn |
| Dec 31, 2014 | -5.15 Mn |
| Sep 30, 2014 | -23.13 Mn |
| Sep 30, 2014 | -23.13 Mn |
| Jun 30, 2014 | -1.97 Mn |
| Jun 30, 2014 | -1.97 Mn |
| Mar 31, 2014 | 21.38 Mn |
| Mar 31, 2014 | 21.38 Mn |
| Dec 31, 2013 | 3.82 Mn |
| Dec 31, 2013 | 3.82 Mn |
| Sep 30, 2013 | 4.89 Mn |
| Sep 30, 2013 | 4.89 Mn |
| Jun 30, 2013 | -2.12 Mn |
| Jun 30, 2013 | -2.12 Mn |
| Mar 31, 2013 | -1.42 Mn |
| Mar 31, 2013 | -1.42 Mn |
| Dec 31, 2012 | -1.95 Mn |
| Dec 31, 2012 | -1.95 Mn |
| Sep 30, 2012 | -1.10 Mn |
| Sep 30, 2012 | -1.10 Mn |
| Jun 30, 2012 | 381,869.00 |
| Jun 30, 2012 | 381,869.00 |
| Mar 31, 2012 | -1.76 Mn |
| Mar 31, 2012 | -1.76 Mn |
| Dec 31, 2011 | -3.36 Mn |
| Dec 31, 2011 | -3.36 Mn |
| Sep 30, 2011 | -2.91 Mn |
| Sep 30, 2011 | -2.91 Mn |
| Jun 30, 2011 | -4.39 Mn |
| Jun 30, 2011 | -4.39 Mn |
| Mar 31, 2011 | 8.17 Mn |
| Mar 31, 2011 | 8.17 Mn |
| Dec 31, 2010 | -3.49 Mn |
| Dec 31, 2010 | -3.49 Mn |
| Sep 30, 2010 | -1.99 Mn |
| Sep 30, 2010 | -1.99 Mn |